Broadly neutralizing antibodies abrogate established hepatitis C virus infection
Science Translational Medicine | September 17, 2014 | Volume: 6 | Issue: 254 | Pages: No page available
10.1126/scitranslmed.3009512
| PMID 25232181
HCV-specific neutralizing antibodies protect humanized mice from challenge and suppress established infections.